drugset / Trial / NCT03590444

Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser

NCT03590444

Phase 4 Completed 50 enrolled Hospital Hietzing
RandomizedParallel-groupOpen-labelTreatment

Summary

Long-term follow-up of patients with diabetic macular edema (DME) treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) combined focal laser and identification of prognostic morphological characteristics.

Timeline

Start
2017-04-02
Primary completion
2018-04-02
Completion
2018-06-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ranibizumab Monoclonal antibody 0.5 mg